Pulmonary Hypertension Clinical Trials
Pulmonary Hypertension clinical trials investigate new drugs, devices, and procedures for pulmonary Hypertension and cardiovascular health. Corterve collects actively recruiting Pulmonary Hypertension studies from the ClinicalTrials.gov registry so you can filter by location and eligibility. Cardiology studies frequently include monitoring of heart function and related measurements. This is general information and not medical advice — review any trial with your cardiologist or physician.
Recruiting Pulmonary Hypertension studies
- Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsNCT06373289NAUniversity of Alabama at BirminghamBronchopulmonary DysplasiaBirmingham, Alabama
- A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)NCT07175038PHASE2AllRock Bio, Inc.Pulmonary Arterial Hypertension (PAH)Phoenix, Arizona
- A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart DiseaseNCT07214376NAPulnovo Medical, Inc.Pulmonary HypertensionTucson, Arizona
- Natural History Study of Biomarkers in Pulmonary Arterial HypertensionNCT01730092National Institutes of Health Clinical Center (CC)Pulmonary DiseaseBethesda, Maryland
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)NCT07179380PHASE3Insmed IncorporatedPulmonary HypertensionPhoenix, Arizona
- LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)NCT05798923PHASE2OrphAI TherapeuticsPulmonary Hypertension Due to Lung Diseases and HypoxiaBirmingham, Alabama
- HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection FractionNCT07123779PHASE1, PHASE235Pharma IncPulmonary HypertensionKansas City, Missouri
- Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)NCT07837830EARLY_PHASE1Valley Health SystemPulmonary HypertensionParamus, New Jersey
- A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)NCT07816185PHASE3Pulmovant, Inc.Pulmonary HypertensionKissimmee, Florida
- A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILDNCT07285655PHASE3Liquidia Technologies, Inc.Pulmonary Hypertension Due to Lung Disease (Disorder)Phoenix, Arizona
- Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionNCT06911632NATempus AIPulmonary HypertensionBirmingham, Alabama
- A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILDNCT07333183PHASE2Pulmovant, Inc.Pulmonary HypertensionSanta Barbara, California
Pulmonary Hypertension trials by state
Pulmonary Hypertension trials by metro
Frequently asked questions
- How do I find recruiting Pulmonary Hypertension clinical trials?
- Browse the actively recruiting Pulmonary Hypertension studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Pulmonary Hypertension clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Pulmonary Hypertension clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.